{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["31(3)"],"submitter":["Couteaux C"],"pubmed_abstract":["After detection of 2 clinical lymphatic filariasis (LF) cases in a postelimination context in 2023 on the island of Futuna (Wallis and Futuna archipelago), the Wallis and Futuna Health Agency conducted a LF prevalence survey in Futuna in May 2024. This cross-sectional study, carried out among schoolchildren <18 years of age, identified 5 children with antigenemia, indicating an estimated antigenemia prevalence in Futuna children nearing 2%. The study also confirmed a spatial cluster of cases in the village of Taoa, where the child antigenemia prevalence reached 7.5% (95% CI 2.1%-18.2%), and demonstrated a link between infection and traditional housing. We observed microfilariae in contact cases during secondary investigations. These findings suggest resurgence of LF in a postelimination context, in which the expected child antigenemia prevalence should not exceed 1%. This situation should prompt a new mass drug administration campaign using triple therapy and the reinforcement of epidemiologic and entomologic surveillance."],"journal":["Emerging infectious diseases"],"pagination":["488-496"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11878298"],"repository":["biostudies-literature"],"pubmed_title":["Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024."],"pmcid":["PMC11878298"],"pubmed_authors":["Takala G","Jessop V","Toa M","Uhila V","Worms B","Couteaux C","Demaneuf T","Lie A","Bien L","Euller D","Munoz M","Selemago MK","Chesimar S","Goarant C"],"additional_accession":[]},"is_claimable":false,"name":"Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024.","description":"After detection of 2 clinical lymphatic filariasis (LF) cases in a postelimination context in 2023 on the island of Futuna (Wallis and Futuna archipelago), the Wallis and Futuna Health Agency conducted a LF prevalence survey in Futuna in May 2024. This cross-sectional study, carried out among schoolchildren <18 years of age, identified 5 children with antigenemia, indicating an estimated antigenemia prevalence in Futuna children nearing 2%. The study also confirmed a spatial cluster of cases in the village of Taoa, where the child antigenemia prevalence reached 7.5% (95% CI 2.1%-18.2%), and demonstrated a link between infection and traditional housing. We observed microfilariae in contact cases during secondary investigations. These findings suggest resurgence of LF in a postelimination context, in which the expected child antigenemia prevalence should not exceed 1%. This situation should prompt a new mass drug administration campaign using triple therapy and the reinforcement of epidemiologic and entomologic surveillance.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2025-04-22T18:38:30.759Z","creation":"2025-04-06T02:31:27.608Z"},"accession":"S-EPMC11878298","cross_references":{"pubmed":["40023805"],"doi":["10.3201/eid3103.241317"]}}